13D Filing: New Leaf Ventures Ii, L.p. and Versartis Inc. (NASDAQ:VSAR)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 4)*

Versartis,
Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

92529L102

(CUSIP Number)

Craig L. Slutzkin

New Leaf Venture Management II, L.L.C.,

Times Square Tower

7
Times Square, Suite 3502

New York, NY 10036

(646) 871-6420

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 20, 2017

(Date of Event which Requires Filing of this Statement)

If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

Note: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

*	The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).

Persons who respond to the collection of information contained in this form are not

required to respond unless the form displays a currently valid OMB control number.

---

CUSIP No. 92529L102		13D		Page 2 of 10 Pages

Schedule 13D

Item 1. Security and Issuer.

This
Amendment No. 4 to the statement on Schedule 13D (this Amendment No. 4) amends and supplements the statement on Schedule 13D filed on April 7, 2014 (the Original 13D, and, together with Amendment No. 1,
Amendment No. 2, Amendment No. 3 and Amendment No. 4, the Schedule 13D) relates to the Common Stock, $0.0001 par value (the Common Stock) of Versartis, Inc. (the Issuer) having its principal
executive office at 4200 Bohannon Drive, Suite 250, Menlo Park, CA 94025.

Certain terms used but not defined in this Amendment No. 4
have the meanings assigned thereto in the Original 13D (and Amendment No. 1, Amendment No. 2 and Amendment No. 3 thereto). Except as specifically provided herein, this Amendment No. 4 does not modify any of the information
previously reported on the Original 13D (and Amendment No. 1, Amendment No. 2 and Amendment No. 3 thereto).

Item 2. Identity and
Background.

This statement is being filed by New Leaf Ventures II, L.P. (NLV II), New Leaf Venture Associates II, L.P.
(NLV Associates) and New Leaf Venture Management II, L.L.C. (NLV Management and together with NLV II and NLV Associates, the Reporting Entities) and Philippe O. Chambon (Chambon), Vijay Lathi
(Lathi), Ronald Hunt (Hunt), Jeani Delagardelle (Delagardelle) and Liam Ratcliffe (Ratcliffe and together with Chambon, Lathi, Hunt and Delagardelle, the Managing Directors). The Reporting
Entities and the Managing Directors collectively are referred to as the Reporting Persons.

The address of the principal
business office of NLV II, NLV Associates, NLV Management, Chambon, Hunt and Ratcliffe is New Leaf Venture Partners, Times Square Tower, 7 Times Square, Suite 3502, New York, NY 10036. The address of the principal business office of Lathi and
Delagardelle is New Leaf Venture Partners, 1200 Park Place, Suite 300, San Mateo, CA 94043.

The principal business of NLV II is to make,
hold and dispose of equity and equity-related investments, principally in healthcare, medical device and life sciences companies. The principal business of NLV Associates is to act as the sole general partner of NLV II. The principal business of NLV
Management is to act as the sole general partner of NLV Associates. The principal business of each of the Managing Directors is to manage the Reporting Entities and a number of affiliated partnerships with similar businesses.

During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has been a party
to a civil proceeding ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Each of NLV II and NLV Associates is a limited partnership organized under the laws of the State of Delaware. NLV Management is a limited
liability company organized under the laws of the State of Delaware. Each Managing Director is a citizen of the United States.

Item 5. Interest in
Securities of the Issuer.

Each of the Reporting Persons has ceased to beneficially own five percent or more of the outstanding shares
of Common Stock.

---

CUSIP No. 92529L102		13D		Page 3 of 10 Pages

Item 7. Material to be Filed as Exhibits.

Exhibit 99.1 Agreement regarding filing of joint Schedule 13D.

Exhibit 99.2 Powers of Attorney regarding Schedule 13D filings.

---

CUSIP No. 92529L102		13D		Page 4 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.

Date:    March 28, 2017

NEW LEAF VENTURES II, L.P.
By:		NEW LEAF VENTURE ASSOCIATES II, L.P.
		General Partner
		By:		NEW LEAF VENTURE MANAGEMENT II, L.L.C.
				General Partner
				By:		*
						Craig L. Slutzkin
						Chief Financial Officer

NEW LEAF VENTURE ASSOCIATES II, L.P.
By:		NEW LEAF VENTURE MANAGEMENT II, L.L.C.
		General Partner
		By:		*
				Craig L. Slutzkin
				Chief Financial Officer
NEW LEAF VENTURE MANAGEMENT II, L.L.C.
		By:		*
				Craig L. Slutzkin
				Chief Financial Officer
*
Philippe O. Chambon
*
Vijay Lathi
*
Ronald Hunt

---

CUSIP No. 92529L102		13D		Page 5 of 10 Pages

*

Jeani Delagardelle

*

Liam Ratcliffe

*	This Schedule 13D was executed by Craig L. Slutzkin on behalf of the individuals listed above pursuant to Powers of Attorney, copies of which are attached as Exhibit 99.4.